BC Cancer’s Molecular Imaging and Therapeutics Program has been recognized with the Canadian Nuclear Isotope Council (CNIC) Award for Academic Leadership — a national honour celebrating the team’s visionary leadership and impact.
At the April CNIC Annual Awards Reception at the National Arts Centre in Ottawa, Dr. François Bénard, senior executive director, Research, BC Cancer accepted the award on behalf the team, including Dr. Joseph Lau, Dr. Carlos Uribe, Dr. Arman Rahmim, Dr. Kuo-Shyan Lin, Dr. Don Wilson and many others.
Congratulations to the Molecular Imaging and Therapeutics Program on this well-deserved recognition. Your leadership in advancing pre-clinical development of PET radiotracers, leading innovative clinical trials and developing new radiopharmaceuticals is helping to expand access to leading-edge, life-changing care for people with cancer throughout British Columbia.
Pictured: James Scongack, Chair, CNIC and Dr. François Bénard.